ARTICLE | Financial News
Pluristem's deal with Chinese investor falls through
June 23, 2017 8:28 PM UTC
Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) disclosed that plans had been terminated for the company to receive a $30 million investment from China's Innovative Medical Management Co. Ltd. (SZSE:002173) (see BioCentury Extra, Oct. 25, 2016).
Pluristem said the deal fell through "due to a recently adopted Chinese policy relating to outbound investments by Chinese companies."...
BCIQ Company Profiles